% | $
Quotes you view appear here for quick access.

Albany Molecular Research Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • stk_nhter stk_nhter Nov 16, 2011 8:56 PM Flag

    amrithebest โ€“ what will happen to the plethora of compounds?

    Ending internal R&D programs eliminates any hope for it to become a pharmaceutical company. Pipeline may get harder and harder to sell as time goes by because of the diminishing lifetime of any patents. Without any loyalty to burn, other chemistry CROs have closed their doors or moved abroad. So why would anyone think about any takeover?

    Does anyone know a chemistry CRO ever paid any dividends? So what is the value to buy this stock?

14.40+0.31(+2.20%)May 27 4:00 PMEDT